Sinocare Inc. Class A 300298

SZSE · China · Health Technology

CNY 16.30+0.20 (+1.24%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Sinocare Inc. Class A 300298

SZSE · China · Health Technology

CNY 16.30+0.20 (+1.24%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

+0.99% · 6MFull-screen chart

Open CNY 16.11High CNY 16.43Low CNY 16.11Close CNY 16.30Volume 3.49M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 16.10
Day range: CNY 16.11 – CNY 16.43
52-week range: CNY 13.37 – CNY 20.32
Volume: 3.49M
Market cap: CNY 9.03B
P/E (TTM): 64.8
Dividend yield (annualized): 1.35%
Next earnings date: 2026-10-22
Avg. volume (1Y): 6.32M

Performance

1 week

-0.24%

1 month

+2.13%

3 months

+10.88%

6 months

+3.82%

Year to date

-8.01%

1 year

-18.21%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Medical Specialties
Country: China
Exchange: SZSE
Shares outstanding: 530.24M
Employees: 5,010
ISIN: CNE100001CJ0
Beta: 0.95

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJul 14, 2026

Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Blood Glucose Monitoring System Market size & share revenue was valued at approximately USD 16.8 Billion in 2025 and is expected to reach USD 18.3 Billion in 2026 and is expected to reach around USD 39.4 Billion by 2035, at a CAGR of 8.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Insulet Corporati

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.